Characterization of Wnt/β-catenin signaling in rhabdomyosarcoma. - Wikidata - wikimedia - TriplyDB

Characterization of Wnt/β-catenin signaling in rhabdomyosarcoma.

Characterization of Wnt/β-catenin signaling in rhabdomyosarcoma.

http://www.wikidata.org/entity/Q39101031

about

Targeting hedgehog signaling reduces self-renewal in embryonal rhabdomyosarcoma Wnt3a: functions and implications in cancer.Combined application of arsenic trioxide and lithium chloride augments viability reduction and apoptosis induction in human rhabdomyosarcoma cell lines.Secreted Frizzled-Related Protein 3 (SFRP3) Is Required for Tumorigenesis of PAX3-FOXO1-Positive Alveolar Rhabdomyosarcoma Glycogen synthase kinase 3 inhibitors induce the canonical WNT/β-catenin pathway to suppress growth and self-renewal in embryonal rhabdomyosarcoma.LEF1 reduces tumor progression and induces myodifferentiation in a subset of rhabdomyosarcoma Preclinical testing of the glycogen synthase kinase-3β inhibitor tideglusib for rhabdomyosarcoma.Using a rhabdomyosarcoma patient-derived xenograft to examine precision medicine approaches and model acquired resistance.Overexpression of the skNAC gene in human rhabdomyosarcoma cells enhances their differentiation potential and inhibits tumor cell growth and spreading.JARID2 and the PRC2 complex regulate skeletal muscle differentiation through regulation of canonical Wnt signaling

P2860

Q33586736-5AEBF4D3-21A1-496A-9D85-8F625B2ED9F9 Q36121065-9AD4521D-764C-48A6-A32C-AFF002A32E8B Q36390944-61A50097-CCB3-4EBD-A2D3-886E8348284B Q36623378-6F1C9274-5881-4620-B494-D67105C42157 Q37702007-5F6A25FE-93EB-44B4-A79D-C72F55D10DE0 Q39103791-10857B5B-98AE-40F8-A092-B4191D754492 Q42032454-BF78AE7E-14B7-44BA-B5B1-F5A034771A45 Q51098298-A105847F-5135-4BE0-8F50-D3E357723C65 Q52873956-5107C8A8-6BBC-4992-B41D-E1E622785DE0 Q58771847-2B573DD7-40D9-4F84-A7B1-F8CFBFF7C904

P2860

Characterization of Wnt/β-catenin signaling in rhabdomyosarcoma.

http://www.wikidata.org/entity/Q39101031

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Characterization of Wnt/β-catenin signaling in rhabdomyosarcoma.

@en

Characterization of Wnt/β-catenin signaling in rhabdomyosarcoma.

@nl

type

label

Characterization of Wnt/β-catenin signaling in rhabdomyosarcoma.

@en

Characterization of Wnt/β-catenin signaling in rhabdomyosarcoma.

@nl

prefLabel

Characterization of Wnt/β-catenin signaling in rhabdomyosarcoma.

@en

Characterization of Wnt/β-catenin signaling in rhabdomyosarcoma.

@nl

P1433

Q39101031-349B4288-E798-40E7-8FB6-DBFFA635F618

P1476

Q39101031-B618733D-F4A6-4738-AA70-52CB02E6337C

P2093

Q39101031-0914DE1B-AA8A-4076-91EB-7C68271F28D0

Q39101031-35E3C9D0-4C06-469C-90B7-FE695637CE17

Q39101031-4FEDE1E2-6F59-4A17-9F63-D97C9C69438F

Q39101031-516F62EB-9309-4612-ADBA-C4673D062D71

Q39101031-824AEC60-2628-4151-B81E-D83E49A37AFB

Q39101031-ED8A2961-13CE-49A0-9600-70793ABEFFC5

Q39101031-F8874A14-3851-4DFE-A0AF-D8B5A8014FD1

P2860

Q39101031-067E0365-9C37-4BAA-93F5-6C54CCC617A7

Q39101031-10B1320F-5A35-432A-809F-4EF12755F385

Q39101031-11A1F5CA-B878-4DDF-A7A2-93E956C75145

Q39101031-15C7D5FC-5B38-441F-BF3F-C6C5B7DD0D6D

Q39101031-22A76A59-A770-445C-B247-430A2867A7DA

Q39101031-2579DC9A-FA0D-4501-B02C-298E901425D9

Q39101031-2CB38FF5-5760-46F9-8D43-401FE8BFDB99

Q39101031-2FD73704-8664-4877-943E-F590BA4C7C03

Q39101031-3AEC8CDD-D909-4336-8BBE-E771A3CBD5AB

Q39101031-4D1C8BEA-D0D2-491B-B489-57F0D854290F

P2888

Q39101031-A653F60D-A71D-453F-9DE4-259F70C8CEAB

P304

Q39101031-43EFE66E-270C-47AD-9E7A-3FF034E12492

P31

Q39101031-1FA234F3-A1D5-479E-A11D-D8D6A78CCA0E

P356

Q39101031-684CE9CE-35A0-41B3-8C82-E03A1FE27CFA

P433

Q39101031-C136C046-DC4F-42C6-B037-91699E3E7AA0

P478

Q39101031-0732536A-264B-4720-8F94-4DBD1C8D3BF4

P50

Q39101031-B9221D4B-8C97-44D8-89FB-4BF63C23CB77

P577

Q39101031-723BD8E6-AE61-46C8-9F91-25ED9CAE9584

P698

Q39101031-D5F0F00E-F93E-4997-BFD6-39727E7620CF

P356

LABINVEST.2013.97

P1433

Laboratory Investigation

P1476

Characterization of Wnt/β-catenin signaling in rhabdomyosarcoma.

@en

P2093

Carlo Dominici

http://www.w3.org/2001/XMLSchema#string

George K Kokai

http://www.w3.org/2001/XMLSchema#string

Heather P McDowell

http://www.w3.org/2001/XMLSchema#string

Samantha Cialfi

http://www.w3.org/2001/XMLSchema#string

Simona Ceccarelli

http://www.w3.org/2001/XMLSchema#string

Stefania Uccini

http://www.w3.org/2001/XMLSchema#string

Timothy R Helliwell

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of c-MYC as a target of the APC pathway

Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells

Human APC sequesters β-catenin even in the absence of GSK-3β in a Drosophila model

Beta-catenin is essential and sufficient for skeletal myogenesis in P19 cells

Regulation of dishevelled and beta-catenin in rat skeletal muscle: an alternative exercise-induced GSK-3beta signaling pathway

Wnt/beta-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway.

Negative feedback loop of Wnt signaling through upregulation of conductin/axin2 in colorectal and liver tumors

Towards an integrated view of Wnt signaling in development

The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway

Wnt signalling and its impact on development and cancer

P2888

labinvest.2013.97

P304

1090-1099

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/LABINVEST.2013.97

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

93

http://www.w3.org/2001/XMLSchema#string

P50

Srinivas R Annavarapu

P577

2013-09-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23999248

http://www.w3.org/2001/XMLSchema#string